期刊
PHARMACEUTICAL RESEARCH
卷 27, 期 11, 页码 2343-2355出版社
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s11095-010-0068-z
关键词
active targeting; block copolymer micelles; epidermal growth factor; intratumoral distribution; passive targeting
资金
- Canadian Institutes of Health Research
- Canadian Breast Cancer Research Alliance
- Ontario Institute for Cancer Research
- Natural Sciences and Engineering Research Council of Canada
- Hoffman-La Roche/Rosemarie Hager
- Lorne F. Lambier
- MDS-Nordion
Block copolymer micelles (BCMs) were functionalized with indium-111 and/or epidermal growth factor (EGF), which enabled investigation of the in vivo transport of passively and actively targeted BCMs. The integration of conventional and image-based techniques afforded novel quantitative means to achieve an in-depth insight into the fate of polymeric nanoparticles in vivo. Pharmacokinetics and biodistribution studies were performed in athymic mice bearing human breast xenografts to evaluate the whole-body transport of NT-BCMs (non-targeted, EGF-) and T-BCMs (targeted, EGF+). The intratumoral distribution of BCMs was investigated using MicroSPECT/CT and autoradiographic imaging, complemented with quantitative MATLABA (R) analyses. Tumors were fractionated for quantifying intracellular uptake of BCMs via gamma-counting. The intratumoral distribution of NT-BCMs and T-BCMs were found to be heterogeneous, and positively correlated with tumor vascularization (r > 0.68 +/- 0.04). The enhanced in vivo cell uptake and cell membrane binding of T-BCMs were found to delay their clearance from tumors overexpressing EGFR, and therefore resulted in enhanced tumor accumulation for the T-BCMs in comparison to the NT-BCMs. Adequate passive targeting is required in order to achieve effective active targeting. Tumor physiology has a significant impact on the transvascular and intratumoral transport of passively and actively targeted BCMs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据